Diabetes

The AJMC^® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

July 17th 2024

Inconsistent Sleep May Heighten Older Adults’ Risk of Diabetes

By Hayden E. Klein

July 15th 2024

What We’re Reading: Cyberattack Exposes Personal Data; Semaglutide May Reduce Dementia Risk; Rural Hospitals Shutdown

By AJMC Staff

July 10th 2024

What We’re Reading: CMS Dementia Care Program; Physician Burnout Drops; Impact of GLP-1 Shortages

By AJMC Staff

July 5th 2024

GLP-1 Agonists May Reduce Cancer Risk for Patients With Diabetes

By Hayden E. Klein

June 21st 2024

Obesity Management in 2024: A Look at the CINEMA Program’s Growth and Impact

By Hayden E. Klein

Video Interviews

View All

April 26th 2024

Dr Yael Mauer Details Underlying Mechanisms of GLP-1s, Patient Benefits

April 25th 2024

Dr Stacey Ehrenberg: More Research Needed on Use of GLP-1s During Pregnancy

April 24th 2024

Dr Diana Isaacs Surveys Emerging Diabetes, Obesity, and Cardiometabolic Treatment Landscape

April 24th 2024

Dr Beau Raymond: How Ochsner’s Digital Program Promotes Tailored Diabetes Management

April 23rd 2024

Dr Robert Zimmerman Discusses Challenges, Adverse Effects of GLP-1 and Multi-Agonist Therapies

April 18th 2024

Dr Beau Raymond on Value-Based Diabetes Care: How Healthy State Initiatives Prevent Downstream Effects

April 15th 2024

Dr Kevin Malloy Discusses the Evolution of GLP-1 Receptor Agonists

January 11th 2024

What Happens to Patients With Diabetes When Semaglutide Dosing Is Disrupted? Dr Ian Neeland Explains

November 21st 2023

Dr Chase Hendrickson Explains Reasons Behind Varying CGM Uptake in Endocrinology, Primary Care Settings

November 8th 2023

Biomarkers of Kidney Disease Progression Have “Transcendent Signals” Across Subtypes, Says Dr Steven Coca

Podcasts

View All

July 11th 2024

Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO

February 15th 2022

How Can Employers Leverage the DPP to Improve Diabetes Rates?

April 22nd 2021

Balancing Care Access and Fragmentation for Better Outcomes in Veterans With Diabetes

February 9th 2021

ChristianaCare Innovates Diabetes Care for Patients With Poorly Controlled Disease

December 1st 2020

Database Helps Clinicians Determine Whether COVID-19 Causes Diabetes

July 5th 2020

Why Amputations Are on the Rise in Some States, Even as Diabetes Care Improves

June 21st 2020

Podcast: This Week in Managed Care—Update on COVID-19 Vaccine Process and Other Health News

June 15th 2020

Beneficiaries Face Limited Access to Medicare Diabetes Prevention Program

June 14th 2020

Podcast: This Week in Managed Care—COVID-19 Funds for Medicaid, CHIP and Other Health News

November 15th 2019

Preventing Chronic Disease in Employees With Early Detection

More News

June 21st 2024

Dr Robert Lustig on Pediatric Metabolic Health: “Sugar Is the Alcohol of the Child”

Hayden E. Klein

Robert Lustig, MD, MSL, explains how the US health care industry needs to shift from measuring body mass index and obesity to measuring cardiometabolic health, which affects 93% of Americans, including children.

What We’re Reading: Change Healthcare Warns of Massive Data Breach; Early Gestational Diabetes Screening; Bird Flu Testing Delays

June 21st 2024

What We’re Reading: Change Healthcare to Send Data Breach Warnings; Early Gestational Diabetes Screening; Bird Flu Testing Delays

AJMC Staff

Change Healthcare will begin notifying individuals whose data may have been exposed when hackers disrupted the claims processing system; experts advocate for early diagnosis of gestational diabetes to mitigate risks for both mother and child; researchers worry that the slow rollout of bird flu tests may hinder outbreak detection and response.

Ozempic | Image credit: mbruxelle – stock.adobe.com

June 20th 2024

WHO Issues Warning for Fake Semaglutide

Hayden E. Klein

Taking falsified semaglutide (Ozempic; Novo Nordisk) can lead to ineffective treatment due to incorrect dosing, contamination, and the use of unknown ingredients, the World Health Organization (WHO) is warning.

June 18th 2024

Age, Insurance Play Major Roles in CGM Use, Says Dr Chase Hendrickson

Hayden E. Klein

Patients with diabetes who have private insurance are more likely to be prescribed a continuous glucose monitor (CGM) compared with those with government insurance, says Chase Hendrickson, MD, MPH, Vanderbilt University Medical Center.

FDA | Image credit: Araki Illustrations – stock.adobe.com

June 13th 2024

FDA Approves Dapagliflozin for Children With Type 2 Diabetes

Hayden E. Klein

Children aged 10 years and older with type 2 diabetes can now improve their glycemic control with a drug previously only approved for adults.

Semaglutide injections | Image credit: Patrick Bay Damsted – stock.adobe.com

May 24th 2024

Semaglutide Lowers Risk of Major Kidney Outcomes, Cardiovascular Events, Death in Patients With Diabetes and CKD

Hayden E. Klein

Patients who took the weekly glucagon-like peptide 1 (GLP-1) receptor agonist were 21% less likely to experience major kidney disease events and 29% less likely to die due to cardiovascular causes.

Supply of tirzepatide | Image credit: MKPhoto – stock.adobe.com

May 16th 2024

Most Insured Adults Still Have to Pay at Least Part of the Cost of GLP-1 Drugs

Hayden E. Klein

Other findings from the latest Kaiser Family Foundation Health Tracking Poll shed light on public awareness, use, and opinions on Medicare coverage of glucagon-like peptide-1 (GLP-1) drugs.

May 6th 2024

Dr Arti Masturzo Gives an In-Depth Look at CCS Survey Results Showing Misconceptions Around Diabetes Management

Hayden E. Klein

Survey results from more than 1500 patients with diabetes revealed that 57% believed glucagon-like peptide-1 (GLP-1) weight loss drugs alone could be a "silver bullet" for managing their health goals.

May 1st 2024

Joanne Mizell: Lifestyle Modification Programs Take Holistic Aim at Metabolic Disease

Giuliana Grossi

Joanne Mizell shares insurer strategies in addressing the escalating rates of metabolic diseases, highlighting the importance of holistic treatment methods like lifestyle modification programs, which integrate nutrition, physical activity, and community engagement.

Continuous glucose monitor | Image credit: habrovich – stock.adobe.com

April 17th 2024

Beyond Insulin: The Impact of Next-Generation Diabetes Technology

Hayden E. Klein Laura Joszt, MA

Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.

April 1st 2024

Medication Persistence and Its Impact on Type 2 Diabetes

Jee H. Choe, MS Si Xuan, PhD Antony Goldenberg, PharmD Jacqueline Matian, PharmD Jeff McCombs, PhD Rory E. Kim, PharmD, MACM, BCACP

Most newly treated patients with type 2 diabetes exhibit suboptimal medication persistence, which is associated with higher risk of hospitalization and increased medical costs.

Woman having eye exam by optometrist | Image Credit: © Nicholas Felix/peopleimages.com - stock.adobe.com

March 19th 2024

Breaking Barriers: Partnerships to Improve Diabetic Eye Health in Alabama

Bryan A. Wilson, PhD, MBA Danielle Haney, PhD Risa Reuscher, PharmD David Tabano, PhD Kimberly Jinnett, PhD Ayesha Ahmed, PharmD Andrew Gordon, MD, PhD Anthony Coleman, BS Raelle Wilson, MA Rachel Israel, BS Jenee Williams, MBA Marina Pevzner Hennessy, MS Terri Wiggins, MS Elizabeth J. Pekas, PhD Raveendhara R. Bannuru, MD, PhD

This article reviews barriers to diabetic eye health across Alabama and highlights a partnership with Genentech and the American Diabetes Association to address this issue.

Survey questionnaire | Image credit: Kay Abrahams peopleimages.com – stock.adobe.com

March 8th 2024

CCS Report Reveals Misconceptions Among People Living With Diabetes; Calls for Enhanced Engagement, Education

Hayden E. Klein

A survey of more than 1500 people revealed misconceptions about living with diabetes, particularly regarding the efficacy of GLP-1 weight loss drugs as a standalone solution for managing their health goals.

March 8th 2024

Improving Glycemic Control in Diabetes Through Virtual Interdisciplinary Rounds

Abby F. Hoffman, PhD Cindy Leslie Roberson, PharmD Pamela Cohen, BA Victoria Lee Jackson, PharmD John Yeatts, MD Patrick Gregory, PharmD Samantha Wong, MD Susan E. Spratt, MD

Patients with diabetes whose providers received advice from remote, virtual interdisciplinary rounds had a greater 1-year reduction in hemoglobin A1c than comparable patients.

FDA Approved | Image credit: chrisdorney – stock.adobe.com

March 6th 2024

FDA Approves First Over-the-Counter Continuous Glucose Monitor

Hayden E. Klein

Starting summer 2024, individuals across the US will be able to purchase a continuous glucose monitor (CGM) without needing a prescription.

March 5th 2024

Out-of-Pocket Costs for Diabetes Medications in Employer-Sponsored Health Insurance Plans

Jennie Quach, MBA Cody Midlam, PharmD Chantell Sell, PharmD Jeff Levin-Scherz, MD, MBA

Out-of-pocket costs of diabetes medications other than insulin can be quite high for individuals with employer-sponsored health insurance.

February 22nd 2024

What We’re Reading: ACA Perception; FDA Blood Sugar Warning; AI and Physician Burnout

AJMC Staff

More than half of US adults have a favorable view of the Affordable Care Act (ACA); smartwatches and rings that claim to measure blood sugar levels without piercing the skin could be dangerous and should be avoided; many believe artificial intelligence (AI) could be the solution to physician burnout.

Diabetes medicine graphic | Image credit: vectorfusionart stock.adobe.com

February 15th 2024

Advancements in Diabetes Technology: Coverage, Challenges, and Pregnancy Considerations

Hayden E. Klein

Expert interviews highlight advancements and challenges in diabetes care technology, including automated insulin delivery systems and continuous glucose monitors, as well as improvements in insurance coverage.

Diabetes management may reduce dementia risk | Image credit: Dragana Gordic – stock.adobe.com

February 12th 2024

Primary Care Diabetes Management May Also Reduce Risk of Dementia

Hayden E. Klein

Participants in the Risk Assessment and Management Program-Diabetes Mellitus had reduced risks of developing all-cause dementia by 28%, Alzheimer disease by 15%, vascular dementia by 39%, and other or unspecified dementia by 29%.

Pill bottle with dollars in it | Image credit: Cagkan – stock.adobe.com

February 9th 2024

Lowering Cardiometabolic Drug Costs May Improve Diabetes Health Outcomes

Hayden E. Klein

Patients enrolled in a preventive drug list (PDL) benefit saw an 8.4% reduction in acute, preventable diabetes complication days, and PDL members residing in lower-income areas saw a 10.2% decrease compared with control members.

pregnant woman using insulin pump | Image credit: lukszczepanski – stock.adobe.com

February 8th 2024

Diabetes Management During Pregnancy: Insights From 3 Specialists

Hayden E. Klein Laura Joszt, MA

Experts explain how diabetes is diagnosed during pregnancy, how treatment differs from that of nonpregnant individuals, the importance of diabetes technology education, and how things change postpartum.

COVID-19 | Image Credit: Production Perig - stock.adobe.com

February 1st 2024

Review: COVID-19 Pandemic Impact on Clinical Outcomes in Patients With Diabetes

Brooke McCormick

This systematic review found COVID-19 disruptions on clinical outcomes in those with diabetes to be more pronounced for females, younger people, and those a part of racial and ethnic minority groups.

Pharmacists conversing | Image credit: Gorodenkoff – stock.adobe.com

January 27th 2024

Impact of a Pharmacist-Managed TOC Clinic on Diabetes Outcomes Following Hospitalization

Hayden E. Klein

While the clinic did not significantly reduce hospital readmission rates for patients with diabetes, it was able to decrease the time to follow-up and improve long-term diabetes outcomes following hospitalization.

The Americas | Image credit: Віталій Баріда – stock.adobe.com

January 25th 2024

Diabetes Mortality Trends Were Stable in the Americas Over 20-Year Period

Hayden E. Klein

An analysis covered trends in mortality caused by diabetes and diabetic kidney disease across North, South, and Central America from 2000 to 2019.

HbA1c test | Image credit: jarun011 – stock.adobe.com

January 23rd 2024

HbA1c Above 6% Linked to Much Greater Diabetes Risk in Adolescents

Hayden E. Klein

Compared with a hemoglobin A1c (HbA1c) level of 5.5%, adolescents with overweight or obesity were 72 times more likely to have diabetes if their HbA1c was 6.3% to 6.4%.

December 28th 2023